The Canadian Severe Acute Respiratory Infection, Prospective, Perpetual Observational Study: Informing Clinical Care and the Public Health Response
加拿大严重急性呼吸道感染前瞻性、永久性观察研究:为临床护理和公共卫生应对提供信息
基本信息
- 批准号:462643
- 负责人:
- 金额:$ 55.45万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-03-01 至 2025-03-01
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Severe acute respiratory infection (SARI) is a major public health problem. Recent outbreaks of pandemic influenza viruses and coronaviruses have taught us not only that these viruses can lead to severe illness and death, but also that it can take a long
严重急性呼吸道感染(Sari)是一个主要的公共卫生问题。最近爆发的大流行性流感病毒和冠状病毒告诉我们,这些病毒不仅可能导致严重的疾病和死亡,而且可能需要很长时间。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fowler Robert A其他文献
Fowler Robert A的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fowler Robert A', 18)}}的其他基金
Canadian Critical Care Trials Group COVID-19 Response: defining critical care capacity in Canada; testing treatments through large-scale adaptive clinical trials; & establishing the evidence base to inform clinical and health system management decisions
加拿大重症监护试验组 COVID-19 响应:定义加拿大的重症监护能力;
- 批准号:
466020 - 财政年份:2022
- 资助金额:
$ 55.45万 - 项目类别:
Directed Grant
Establishing Feasibility & Safety of Providing Critical Care Treatments for Patients with Ebola in a Simulated Ebola Treatment Centre: Phase 2
建立可行性
- 批准号:
462610 - 财政年份:2022
- 资助金额:
$ 55.45万 - 项目类别:
Operating Grants
Canadian Critical Care Trials Group COVID-19 Response: defining critical care capacity in Canada; testing treatments through large-scale adaptive clinical trials; & establishing the evidence base to inform clinical and health system management decisions
加拿大重症监护试验组 COVID-19 响应:定义加拿大的重症监护能力;
- 批准号:
465699 - 财政年份:2022
- 资助金额:
$ 55.45万 - 项目类别:
Directed Grant
The Canadian Network of COVID-19 Clinical Trials Networks
加拿大 COVID-19 临床试验网络
- 批准号:
440348 - 财政年份:2020
- 资助金额:
$ 55.45万 - 项目类别:
Operating Grants
The Canadian Critical Care Trials Group
加拿大重症监护试验组
- 批准号:
426781 - 财政年份:2020
- 资助金额:
$ 55.45万 - 项目类别:
Operating Grants
The Canadian Severe Acute Respiratory Infection, Prospective, Perpetual Observational Study: Informing Clinical Care and the Public Health Response
加拿大严重急性呼吸道感染前瞻性、永久性观察研究:为临床护理和公共卫生应对提供信息
- 批准号:
442907 - 财政年份:2020
- 资助金额:
$ 55.45万 - 项目类别:
Operating Grants
Regional and temporal variations in incidence, prevalence and outcomes of critical illness among pregnant and post-partum women and newborns in Canada
加拿大孕妇、产后妇女和新生儿危重疾病发病率、患病率和结果的区域和时间差异
- 批准号:
322270 - 财政年份:2015
- 资助金额:
$ 55.45万 - 项目类别:
Operating Grants
Establishing Feasibility & Safety of Providing Critical Care for Patients with Ebola through design of a simulated Ebola Treatment Centre
建立可行性
- 批准号:
331214 - 财政年份:2015
- 资助金额:
$ 55.45万 - 项目类别:
Operating Grants
Regional and temporal variations in incidence, prevalence and outcomes of critical illness among pregnant and post-partum women and newborns in Canada
加拿大孕妇、产后妇女和新生儿危重疾病发病率、患病率和结果的区域和时间差异
- 批准号:
267407 - 财政年份:2012
- 资助金额:
$ 55.45万 - 项目类别:
Operating Grants
A National Comparison of Intensity of End-of-Life Care in Canada: Defining Changing Patterns, Risk Factors and Targets for Intervention.
加拿大临终关怀强度的全国比较:定义不断变化的模式、风险因素和干预目标。
- 批准号:
231446 - 财政年份:2011
- 资助金额:
$ 55.45万 - 项目类别:
Operating Grants
相似海外基金
Developing an infection-blocking pan-coronavirus vaccine
开发阻断感染的泛冠状病毒疫苗
- 批准号:
MR/Y019466/1 - 财政年份:2024
- 资助金额:
$ 55.45万 - 项目类别:
Research Grant
Development of Teat-Dipping Nanoemulsion Loaded with Curcumin for Prevention of Intramammary Infection and Treatment of Mastitis as an Immune Stimulant
开发含有姜黄素的乳头浸渍纳米乳作为免疫兴奋剂预防乳房内感染和治疗乳腺炎
- 批准号:
24K09263 - 财政年份:2024
- 资助金额:
$ 55.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of bactericidal bone substitutes to prevent surgical site infection
开发杀菌骨替代物以预防手术部位感染
- 批准号:
24K19916 - 财政年份:2024
- 资助金额:
$ 55.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Omics approaches to decipher infection clearance and resolution in eukaryotic human pathogens
破译真核人类病原体感染清除和解决的组学方法
- 批准号:
502579 - 财政年份:2024
- 资助金额:
$ 55.45万 - 项目类别:
Integrating subcellular multi-omics to identify druggable metabolic markers of latent HIV infection in CD4 T-cells
整合亚细胞多组学来识别 CD4 T 细胞中潜在 HIV 感染的可药物代谢标志物
- 批准号:
MR/Y013093/1 - 财政年份:2024
- 资助金额:
$ 55.45万 - 项目类别:
Research Grant
Uncovering the unconventional and multifaceted roles of histamine in bacterial infection
揭示组胺在细菌感染中的非常规和多方面的作用
- 批准号:
502559 - 财政年份:2024
- 资助金额:
$ 55.45万 - 项目类别:
Presymptom: development of a novel machine-learning-derived diagnostic test to rule out infection to enable enhanced clinical care and better targeted anti-microbial use
症状前:开发一种新型的机器学习诊断测试来排除感染,从而加强临床护理和更有针对性的抗菌药物使用
- 批准号:
10089281 - 财政年份:2024
- 资助金额:
$ 55.45万 - 项目类别:
Investment Accelerator
Cannabinoids, Inflammation/Infection and Microglia: Relation to Brain and Behaviour
大麻素、炎症/感染和小胶质细胞:与大脑和行为的关系
- 批准号:
502602 - 财政年份:2024
- 资助金额:
$ 55.45万 - 项目类别:
Controlled Human Infection Models for advancing pertussis research and novel vaccine development
用于推进百日咳研究和新型疫苗开发的受控人类感染模型
- 批准号:
502603 - 财政年份:2024
- 资助金额:
$ 55.45万 - 项目类别:
Use of Opsonophagocytic Assay for Serological Evaluation of SimCell vaccines against Pseudomonas aeruginosa infection
使用调理吞噬试验对针对铜绿假单胞菌感染的 SimCell 疫苗进行血清学评估
- 批准号:
10108204 - 财政年份:2024
- 资助金额:
$ 55.45万 - 项目类别:
Collaborative R&D